0001437749-24-007031.txt : 20240307
0001437749-24-007031.hdr.sgml : 20240307
20240307212152
ACCESSION NUMBER: 0001437749-24-007031
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240305
FILED AS OF DATE: 20240307
DATE AS OF CHANGE: 20240307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jiang Tianyi
CENTRAL INDEX KEY: 0001865596
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39048
FILM NUMBER: 24732141
MAIL ADDRESS:
STREET 1: C/O AVEPOINT, INC.
STREET 2: 525 WASHINGTON BOULEVARD, SUITE 1400
CITY: JERSEY CITY
STATE: NJ
ZIP: 07310
FORMER NAME:
FORMER CONFORMED NAME: Jiang Tiany
DATE OF NAME CHANGE: 20210603
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AvePoint, Inc.
CENTRAL INDEX KEY: 0001777921
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372]
ORGANIZATION NAME: 06 Technology
IRS NUMBER: 834461709
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 525 WASHINGTON BLVD
STREET 2: SUITE 1400
CITY: JERSEY CITY
STATE: NJ
ZIP: 07310
BUSINESS PHONE: (201) 793-1111
MAIL ADDRESS:
STREET 1: 525 WASHINGTON BLVD
STREET 2: SUITE 1400
CITY: JERSEY CITY
STATE: NJ
ZIP: 07310
FORMER COMPANY:
FORMER CONFORMED NAME: Apex Technology Acquisition Corp
DATE OF NAME CHANGE: 20190528
4
1
rdgdoc.xml
FORM 4
X0508
4
2024-03-05
0001777921
AvePoint, Inc.
AVPT
0001865596
Jiang Tianyi
C/O AVEPOINT, INC.
525 WASHINGTON BOULEVARD, SUITE 1400
JERSEY CITY
NJ
07310
1
1
1
Chief Executive Officer
0
Common Stock
2024-03-05
4
A
0
134048
0
A
586599
D
Stock Option (Right to Buy)
7.46
2024-03-05
4
A
0
234960
7.46
A
2025-03-05
2035-03-05
Common Stock
234960
5888197
D
This security represents the Issuer's common stock as well as restricted stock units (each, an "RSU") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
Represents performance-based RSUs based upon two metrics: FY25 GAAP Profitability and Non-GAAP Rule of 40. Actual payouts may represent 50% to 150% of granted value. These performance-based RSUs will vest 50% on March 5, 2026, and then 25% annually after, using FY25 as the performance period.
Includes aggregate vested and unvested RSUs held by the Reporting Person subject to the vesting schedules previously reported on Table I on a Form 4 filed with the Securities and Exchange Commission on September 3, 2021, March 22, 2022 and March 23, 2023.
This security represents options to purchase the Issuer's common stock granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan.
25% of the shares underlying this option will vest on March 5, 2025, and the remaining options vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.
This security represents options to purchase the Issuer's common stock granted to the reporting person under the Issuer's 2021 Equity Incentive Plan. Each option represents the contingent right to receive, upon exercise of the option, one share of the Issuer's common stock.
/s/ Brian Michael Brown, Attorney-in-Fact
2024-03-07